The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Normal and Pathologic Concentrations of Uremic Toxins
Open accessAbstract
An updated review of the existing knowledge regarding uremic toxins facilitates the design of experimental studies. We performed a literature search and found 621 articles about uremic toxicity published after a 2003 review of this topic. Eighty-seven records provided serum or blood measurements of one or more solutes in patients with CKD. These records described 32 previously known uremic toxins and 56 newly reported solutes. The articles most frequently reported concentrations of β2-microglobulin, indoxyl sulfate, homocysteine, uric acid, and parathyroid hormone. We found most solutes (59%) in only one report. Compared with previous results, more recent articles reported higher uremic concentrations of many solutes, including carboxymethyllysine, cystatin C, and parathyroid hormone. However, five solutes had uremic concentrations less than 10% of the originally reported values. Furthermore, the uremic concentrations of four solutes did not exceed their respective normal concentrations, although they had been previously described as uremic retention solutes. In summary, this review extends the classification of uremic retention solutes and their normal and uremic concentrations, and it should aid the design of experiments to study the biologic effects of these solutes in CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
David, F. N., & Tukey, J. W. (1977) · Biometrics · doi:10.2307/2529486 · Cited by 12,708
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Block, G. A., Klassen, P. S., Lazarus, J. M., Ofsthun, N., Lowrie, E. G., & Chertow, G. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000133041.27682.a2 · Cited by 2,687
Review on uremic toxins: Classification, concentration, and interindividual variability
Vanholder, R., For the European Uremic Toxin Work Group (EUTox), De Smet, R., Glorieux, G., Argilés, A., Baurmeister, U., Brunet, P., Clark, W., Cohen, G., De Deyn, P. P., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00924.x · Cited by 1,720
Self-citationThe role of vascular endothelial growth factor (VEGF) in renal pathophysiology
Schrijvers, B. F., Flyvbjerg, A., & De Vriese, A. S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00621.x · Cited by 504
Serum β-2 Microglobulin Levels Predict Mortality in Dialysis Patients: Results of the HEMO Study
Cheung, A. K., Rocco, M. V., Yan, G., Leypoldt, J. K., Levin, N. W., Greene, T., Agodoa, L., Bailey, J., Beck, G. J., Clark, W., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005020132 · Cited by 453
Liabeuf, S., Barreto, D. V., Barreto, F. C., Meert, N., Glorieux, G., Schepers, E., Temmar, M., Choukroun, G., Vanholder, R., Massy, Z. A., et al. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp592 · Cited by 431
Self-citationColonic Contribution to Uremic Solutes
Aronov, P. A., Luo, F. J.-G., Plummer, N. S., Quan, Z., Holmes, S., Hostetter, T. H., & Meyer, T. W. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121220 · Cited by 422
Bammens, B., Evenepoel, P., Keuleers, H., Verbeke, K., & Vanrenterghem, Y. (2006) · Kidney International · doi:10.1038/sj.ki.5000115 · Cited by 388
Shigematsu, T., Kazama, J. J., Yamashita, T., Fukumoto, S., Hosoya, T., Gejyo, F., & Fukagawa, M. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.04.029 · Cited by 326
Yu, M., Kim, Y. J., & Kang, D.-H. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05340610 · Cited by 314
Levels of Soluble Cell Adhesion Molecules in Patients With Dyslipidemia
Hackman, A., Abe, Y., Insull, W., Pownall, H., Smith, L., Dunn, K., Gotto, A. M., & Ballantyne, C. M. (1996) · Circulation · doi:10.1161/01.cir.93.7.1334 · Cited by 310
Increased Serum Levels of 8-Hydroxy-2′-Deoxyguanosine in Clinical Depression
Forlenza, M. J., & Miller, G. E. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000195780.37277.2a · Cited by 308
Hida, M., Aiba, Y., Sawamura, S., Suzuki, N., Satoh, T., & Koga, Y. (2008) · Nephron · doi:10.1159/000189334 · Cited by 295
Bain, M. A., Faull, R., Fornasini, G., Milne, R. W., & Evans, A. M. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfk056 · Cited by 282
Removal of P-Cresol Sulfate by Hemodialysis
Martinez, A. W., Recht, N. S., Hostetter, T. H., & Meyer, T. W. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005030310 · Cited by 262
Zoungas, S., McGrath, B. P., Branley, P., Kerr, P. G., Muske, C., Wolfe, R., Atkins, R. C., Nicholls, K., Fraenkel, M., Hutchison, B. G., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.064 · Cited by 241
Nakabayashi, I., Nakamura, M., Kawakami, K., Ohta, T., Kato, I., Uchida, K., & Yoshida, M. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq624 · Cited by 214
Isolation of angiogenin from normal human plasma
Shapiro, R., Strydom, D. J., Olson, K. A., & Vallee, B. L. (1987) · Biochemistry · doi:10.1021/bi00390a037 · Cited by 190
Niwa, T., Takeda, N., Tatematsu, A., & Maeda, K. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.11.2264 · Cited by 188
de Loor, H., Bammens, B., Evenepoel, P., De Preter, V., & Verbeke, K. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.050781 · Cited by 186
Metabolite Profiling Identifies Markers of Uremia
Rhee, E. P., Souza, A., Farrell, L., Pollak, M. R., Lewis, G. D., Steele, D. J. R., Thadhani, R., Clish, C. B., Greka, A., & Gerszten, R. E. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009111132 · Cited by 184
Sarris, A. H., Kliche, K.-O., Pethambaram, P., Preti, A., Tucker, S., Jackow, C., Messina, O., Pugh, W., Hagemeister, F. B., McLaughlin, P., et al. (1999) · Annals of Oncology · doi:10.1023/a:1008301602785 · Cited by 167
Self-citationUremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients
Lim, W. H., Kireta, S., Leedham, E., Russ, G. R., & Coates, P. T. (2007) · Kidney International · doi:10.1038/sj.ki.5002425 · Cited by 162
Metabolomic profiling of uremic solutes in CKD patients
Toyohara, T., Akiyama, Y., Suzuki, T., Takeuchi, Y., Mishima, E., Tanemoto, M., Momose, A., Toki, N., Sato, H., Nakayama, M., et al. (2010) · Hypertension Research · doi:10.1038/hr.2010.113 · Cited by 160
Guebre‐Egziabher, F., Bernhard, J., Funahashi, T., Hadj‐Aïssa, A., & Fouque, D. P. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh568 · Cited by 159
Uridine adenosine tetraphosphate: a novel endothelium- derived vasoconstrictive factor
Jankowski, V., Tölle, M., Vanholder, R. C., Schönfelder, G., van der Giet, M., Henning, L., Schlüter, H., Paul, M., Zidek, W., & Jankowski, J. (2005) · Nature Medicine · doi:10.1038/nm1188 · Cited by 155
Self-citationHuman alpha1-microglobulin. Purification procedure, chemical and physiochemical properties.
Ekström, B., & Berggård, I. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40934-3 · Cited by 136
Beltran, L., Fahie‐Wilson, M. N., McKenna, T. J., Kavanagh, L., & Smith, T. P. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.105312 · Cited by 135
Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression
Jankowski, J., van der Giet, M., Jankowski, V., Schmidt, S. C., Hemeier, M., Mahn, B., Giebing, G., Tölle, M., Luftmann, H., Schlüter, H., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15524 · Cited by 134
Self-citationd’Herbomez, M., Caron, P. J., Bauters, C., Cao, C. D., Schlienger, J.-L., Sapin, R., Baldet, L., Carnaille, B. M. L., Wémeau, J.-L., & _, _. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0566 · Cited by 133
Metabolism of complement factor D in renal failure
Pascual, M. A., Steiger, G., Estreicher, J., Macon, K. J., Volanakis, J. E., & Schifferli, J. A. (1988) · Kidney International · doi:10.1038/ki.1988.214 · Cited by 126
Hemodialysis Acutely Improves Hepatic CYP3A4 Metabolic Activity
Nolin, T. D., Appiah, K. K., Kendrick, S. A., Le, P. T., McMonagle, E., & Himmelfarb, J. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006060610 · Cited by 126
Horowitz, J. D., & Heresztyn, T. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.09.023 · Cited by 122
Jourde‐Chiche, N., Dou, L., Sabatier, F., Calaf, R., Cérini, C., Robert, S., Camoin‐Jau, L., Charpiot, P., Argilés, À., Dignat‐George, F., et al. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03540.x · Cited by 116
Kabanda, A., Jadoul, M. Y., Jm, P., Lauwerys, R., de Strihou, C. V. Y., & Bernard, A. (1994) · Kidney International · doi:10.1038/ki.1994.221 · Cited by 115
Leptin as a Uremic Toxin Interferes with Neutrophil Chemotaxis
Ottonello, L. C., Gnerre, P., Bertolotto, M. B., Mancini, M., Dapino, P., Russo, R., Garibotto, G., BARRECA, T., & Dallegri, F. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000139321.98029.40 · Cited by 115
Indoxyl Sulfate and Atherosclerotic Risk Factors in Hemodialysis Patients
Taki, K., Tsuruta, Y., & Niwa, T. (2007) · American Journal of Nephrology · doi:10.1159/000098542 · Cited by 112
Rysz, J., Banach, M., Ciałkowska-Rysz, A. D., Stolarek, R. A., Barylski, M., Dróżdż, J., & Okoński, P. (2006) · PubMed · Cited by 109
Smet, R. D., Dhondt, A., Eloot, S., Galli, F., Waterloos, M., & Vanholder, R. C. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm065 · Cited by 103
Self-citationWarning: the unfortunate end of p-cresol as a uraemic toxin
Vanholder, R., Bammens, B., de Loor, H., Glorieux, G., Meijers, B. K. I., Schepers, E., Massy, Z. A., & Evenepoel, P. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr056 · Cited by 100
Self-citationN-methyl-2-pyridone-5-carboxamide: A novel uremic toxin?
Rutkowski, B., Slominska, E. M., Szołkiewicz, M., Smolenski, R. T., Striley, C., Rutkowski, P., & Świerczyński, J. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.s84.36.x · Cited by 98
ELISA of pentosidine, an advanced glycation end product, in biological specimens
Taneda, S., & Monnier, V. M. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.9.1766 · Cited by 89
Serum Carboxymethyllysine Predicts Mortality in Hemodialysis Patients
Wagner, Z., Molnár, M., Molnár, G. A., Tamaskó, M., Laczy, B., Wagner, L. J., Csiky, B. S., Heidland, A., Nagy, J., & Wittmann, I. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.010 · Cited by 86
Brandenburg, V. M., Schlieper, G., Heussen, N. M., Holzmann, S., Busch, B., Evenepoel, P., Vanholder, R., Meijers, B. K. I., Meert, N., Faßbender, W. J., et al. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq053 · Cited by 83
Self-citationKielstein, J. T., Böger, R. H., Bode‐Böger, S. M., Martens‐Lobenhoffer, J., Lonnemann, G., Frölich, J. C., Haller, H. G., & Fliser, D. (2004) · Clinical Nephrology · doi:10.5414/cnp62295 · Cited by 81
Pre-dilution on-line haemofiltration vs low-flux haemodialysis: a randomized prospective study
Beerenhout, C. H., Luik, A. J., Jeuken-Mertens, S. G. J. S., Bekers, O., Menheere, P. P. C. A., Hover, L., Klaassen, L., SANDE, F. M. V. D., Cheriex, E. C., Meert, N., et al. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh775 · Cited by 79
Relationship of Impaired Olfactory Function in ESRD to Malnutrition and Retained Uremic Molecules
Raff, A. C., Lieu, S., Melamed, M. L., Quan, Z., Ponda, M. P., Meyer, T. W., & Hostetter, T. H. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.02.301 · Cited by 78
Friedrich, N., Alte, D., Völzke, H., Spilcke-Liss, E., Lüdemann, J., Lerch, M. M., Kohlmann, T., Nauck, M. A., & Wallaschofski, H. (2007) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2007.09.005 · Cited by 75
Stinghen, A. E. M., Gonçalves, S., Martines, E. G., Nakao, L. S., RIELLA, M. C., Aita, C. A. M., & Pecoits‐Filho, R. (2009) · Nephron Clinical Practice · doi:10.1159/000191205 · Cited by 74
Plasma guanidino compounds are altered by oral creatine supplementation in healthy humans
Derave, W., Marescau, B., Eynde, E. V., Eijnde, B. O., Deyn, P. P. D., & Hespel, P. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00206.2004 · Cited by 64
Accumulation of cyanide and thiocyanate in haemodialysis patients
Hasuike, Y., Nakanishi, T., Moriguchi, R., Otaki, Y., Nanami, M., Hama, Y., Naka, M., Miyagawa, K., Izumi, M., & Takamitsu, Y. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh076 · Cited by 64
Schepers, E., Glorieux, G., Dou, L., Cérini, C., Gayrard, N., Louvet, L., Maugard, C., Preus, P., Rodríguez-Ortiz, M. E., Argilés, À., et al. (2010) · Blood Purification · doi:10.1159/000320765 · Cited by 61
Self-citationDagogo-Jack, S. E., Ovalle, F., Landt, M., Gearing, B. K., & Coyne, D. W. (1998) · Peritoneal Dialysis International · doi:10.1177/089686089801800103 · Cited by 59
Oral Adsorbent AST-120 Decreases Serum Levels of AGEs in Patients with Chronic Renal Failure
Ueda, S., Yamagishi, S., Takeuchi, M., Kohno, K., Shibata, R., Matsumoto, Y., Kaneyuki, U., Fujimura, T., Hayashida, A., & Okuda, S. (2006) · Molecular Medicine · doi:10.2119/2005-00034.ueda · Cited by 59
Effects of Hemodialysis, Dialyser Type and Iron Infusion on Oxidative Stress in Uremic Patients
Müller, C., Eisenbrand, G., Gradinger, M., Rath, T., Albert, F. W., Vienken, J., Singh, R., Farmer, P. B., Stockis, J., & Janzowski, C. (2004) · Free Radical Research · doi:10.1080/10715760400011452 · Cited by 58
Respective role of uraemic toxins and myeloperoxidase in the uraemic state
Capeillère‐Blandin, C., Gausson, V., Nguyen, A., Descamps‐Latscha, B., Drüeke, T. B., & Witko‐Sarsat, V. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl007 · Cited by 58
Berrahmoune, H., Lamont, J. V., Herbeth, B., FitzGerald, P. S., & Visvikis-Siest, S. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.055798 · Cited by 56
Guanidino compounds in uraemic dialysed patients
Deyn, P. P. D., Marescau, B., Lornoy, W., Becaus, I., & Löwenthal, A. (1986) · Clinica Chimica Acta · doi:10.1016/0009-8981(86)90220-2 · Cited by 55
Binding of Hippurate in Normal Plasma and in Uremic Plasma Pre- and Postdialysis
Farrell, P. C., Gotch, F. A., Peters, J. H., Berridge, B. J., & Lam, M. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000181194 · Cited by 55
Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis
Fragedaki, E., Nebel, M., Schupp, N., Šebeková, K., Völkel, W., Klassen, A., Pischetsrieder, M., Frischmann, M., Niwa, T., Vienken, J., et al. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh898 · Cited by 49
Schuchardt, M., Tölle, M., Prüfer, J., Prüfer, N., Huang, T., Jankowski, V., Jankowski, J., Zidek, W., & van der Giet, M. (2011) · Kidney International · doi:10.1038/ki.2011.326 · Cited by 40
Self-citationTaes, Y., Marescau, B., Vriese, A. S. D., Deyn, P. P. D., Schepers, E., Vanholder, R., & Delanghe, J. R. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm793 · Cited by 40
Self-citationEffective removal of leptin via hemodiafiltration with on-line endogenous reinfusion therapy
Kim, S., Oh, K. H., Chin, H. J., et al. (2009) · Clinical Nephrology · doi:10.5414/cnp72442 · Cited by 40
Association Between Indoxyl Sulfate and Skeletal Resistance in Hemodialysis Patients
Goto, S., Fujii, H., Hamada, Y., Yoshiya, K., & Fukagawa, M. (2010) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2010.00813.x · Cited by 38
Újhelyi, L., Balla, G., Jeney, V., Varga, Z., Nagy, E., Vercellotti, G. M., Agarwal, A., Eaton, J. W., & Balla, J. (2005) · Kidney International · doi:10.1038/sj.ki.5000007 · Cited by 33
Scholze, A., Jankowski, V., Henning, L., Haaß, W., Wittstock, A., Suvd-Erdene, S., Zidek, W., Tepel, M., & Jankowski, J. (2007) · Nephron Clinical Practice · doi:10.1159/000105137 · Cited by 31
Self-citationRelationship between uremic toxins and oxidative stress in patients with chronic renal failure
Rutkowski, P., Slominska, E. M., Szołkiewicz, M., Aleksandrowicz, E., Smolenski, R. T., Wołyniec, W., Renke, M., Wisterowicz, K., Świerczyński, J., & Rutkowski, B. (2006) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365590601017170 · Cited by 29
Kock, R., Delvoux, B., Sigmund, M., & Greiling, H. (1994) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1994.32.11.837 · Cited by 28
The differences of asymmetric dimethylarginine removal by different dialysis treatments
Zhang, D., Liu, J., Liu, S., Zhang, Y., & Liu, W. (2010) · Renal Failure · doi:10.3109/0886022x.2010.502281 · Cited by 22
Cited by
The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease
Yang, T., Richards, E. M., Pepine, C. J., & Raizada, M. K. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0018-2 · Cited by 753
The Uremic Toxicity of Indoxyl Sulfate and p-Cresyl Sulfate: A Systematic Review
Vanholder, R., Schepers, E., Pletinck, A., Nagler, E. V., & Glorieux, G. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013101062 · Cited by 683
Self-citationWhat do drug transporters really do?
Nigam, S. K. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4461 · Cited by 527
Trimethylamine N-oxide: the good, the bad and the unknown.
Velasquez, M., Ramezani, A., Manal, A., & Raj, D. (2016) · Toxins · doi:10.3390/toxins8110326 · Cited by 504
Endothelium structure and function in kidney health and disease
Jourde-Chiche, N., Fakhouri, F., Dou, L., Bellien, J., Burtey, S., Frimat, M., Jarrot, P.-A., Kaplanski, G., Le Quintrec, M., Pernin, V., et al. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0098-z · Cited by 493
Metadata
- Authors
- Duranton, F., Cohen, G., De Smet, R., Rodriguez, M., Jankowski, J., Vanholder, R., & Argiles, A.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2012-07
- Volume
- 23
- Issue
- 7
- Pages
- 1258-1270
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2145073188
- Cited by
- 961
- References
- 69
- FWCI
- 31.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.